Hepatocellular carcinoma. A worldwide problem and the major risk factors.
about
Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaNodule in Liver: Investigations, Differential Diagnosis and Follow-upAntioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migrationComparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysisEffect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trialIncidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity areaGenomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of actionChallenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringCirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulatorsDe-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma.Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver.Current management of hepatocellular carcinoma.Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorHepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinomaA cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.Vaccination against hepatitis B: current challenges for Asian countries and future directions.Hepatocellular carcinoma in the world and the middle East.Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma.Epidemiology and carcinogenesis of hepatocellular carcinoma.The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industryComprehensive genetic analysis of cancer cells.Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis.The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro studyHepatitis B and alcohol affect survival of hepatocellular carcinoma patients.Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradeChemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinomaHepatocellular carcinoma in Central Europe: prognostic features and survival.Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre studyHepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives.Hepatocellular carcinoma in Asia: Prevention strategy and planning.Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profileSubcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance.Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
P2860
Q26772334-46809C15-A1E5-40D5-A69F-FB5329433903Q27015959-F777713B-C38F-4C00-96CB-A5CCB60EACD1Q27027482-5EAECCE0-17A9-40A1-B11E-2AFA6A107CCAQ28067018-17E1F0C2-62C4-4532-ACA3-6AAFFCAF3EC0Q28361953-FA7FB60B-A9B6-4EA0-B578-F260440B2CC2Q28397139-DAC1FA2B-0020-4C42-ACE3-E099B191CD52Q28541142-9C3F2C19-1E4E-4EE6-B9F6-B63CC2E7ADF4Q30398077-C302BC4B-4723-480B-8DB8-51DEDE8FB96DQ30436747-137D8E62-E1F5-4BA9-8E81-FB9B7C5D90F1Q30832108-1D067C6F-DF35-4416-BEE1-E8A93E013D40Q31938591-E46394D1-EFCC-4413-8A8D-1EE1B7D0FB19Q32100816-90E8F5B3-1EDD-4752-BE2A-D151C886FB61Q33208655-7E13E031-5F92-489E-92C9-86E2D3DE33BFQ33582165-5C84070F-979A-4BD1-8E5E-BD1F7E7C7AB3Q33629414-46268556-E23E-400F-98DF-B439A278998AQ33866448-B6843055-EABD-48CA-AAE1-924B50258B60Q33868149-A4910E9B-B7DD-4F10-A4E4-9BAABA555A54Q33895863-B2F9F314-26B4-4398-B0D3-C1BDA508401AQ33926147-181897D9-CFD3-4A3C-B46F-08CC723C6CADQ34134967-9D2FB2C0-17AD-47D9-A523-61EC358D589FQ34138916-F92C58B8-4A87-4A57-B147-5F2B1BF842A7Q34517734-D88C6CBA-1CC5-403D-85B9-3CCE94077F1EQ34589304-4CEF4A8E-C4E9-4199-BF10-3E1159F5067DQ34640703-EEB8AE7C-93F4-4C1A-A0F6-B8120357E980Q34776622-0184B181-6E26-4672-A332-1F4A88C64C70Q34939487-A0E076A1-CA20-4CDA-9801-FF45E6CB7B73Q35014932-78E461E4-E509-4013-81A5-27A3084FEE50Q35045196-DA1D47FF-747D-4300-ABB4-DC66AE7E2A01Q35065472-8C00B98B-12F8-442B-BF57-9C33B3DC166CQ35168279-F8459D6D-4442-4C8E-B12C-0267EFBA98A0Q35362327-402EB6C1-BAD6-49F7-AF34-5B42B4EFC8B7Q35362361-A82127BE-241C-4B2B-9600-4F220A9558F0Q35387908-7E48804D-C8BA-4F22-84B0-25A94598A1DEQ35596794-A3A9F520-F136-42FD-A36F-0BD230A3DF85Q35626757-B7B45DDB-CB95-4CC1-86BE-03541BBABE01Q35626761-925C710C-3C36-4346-A3A6-9A48C70A3B5CQ35790424-25DDDB8F-C64F-4DE6-9FFA-52800C9D17EDQ35795014-75B95524-2465-43DA-97BF-BBA8175E0CE2Q35795731-7D6CF14C-74F7-48D9-9E42-FD2643EDD2B0Q35870607-E004EB7F-DFE8-4657-A0E5-64E8F25EF9C6
P2860
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@ast
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@en
type
label
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@ast
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@en
prefLabel
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@ast
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@en
P2093
P356
P1476
Hepatocellular carcinoma. A worldwide problem and the major risk factors.
@en
P2093
P2888
P304
P356
10.1007/BF01297149
P577
1991-07-01T00:00:00Z